Table 4 Infectious complications
From: Tailored immunosuppression after kidney transplantation - a single center real-life experience
Type of induction therapya | ||||
|---|---|---|---|---|
No induction (n = 99) | Basiliximab (n = 46) | Thymoglobulin (n = 47) | P-value | |
Bacterial infection, n (%) | 35 (36.8) | 13 (28.9) | 16 (36.4) | 0.633 |
Viremia, n (%) | ||||
Cytomegalovirus | 59 (61.5) | 17 (37.0) | 23 (51.1) | 0.023 |
BK Polyomavirus | 25 (26.0) | 15 (32.6) | 17 (37.8) | 0.346 |
Hospitalisation due to | ||||
Infection, n (%) | 37 (38.9) | 14 (31.1) | 18 (40.9) | 0.581 |